Skip to main content
Ajooni Biotech Limited logo

Ajooni Biotech Limited — Investor Relations & Filings

Ticker · AJOONI ISIN · INE820Y01021 LEI · 335800OAKJWKHF49O339 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 562 across all filing types
Latest filing 2021-08-14 Board/Management Inform…
Country IN India
Listing National Stock Exchange of India AJOONI

About Ajooni Biotech Limited

https://www.ajoonibiotech.com

Ajooni Biotech Limited specializes in the production and distribution of animal healthcare solutions and nutritional supplements. The company focuses on the livestock sector, offering a comprehensive range of products including compounded cattle feed, mineral mixtures, and specialized supplements formulated to enhance milk productivity and overall animal health. Its portfolio features calcium supplements, liver tonics, and digestive aids designed to meet the specific nutritional needs of dairy animals. The company utilizes research-driven formulations and quality-controlled manufacturing processes to provide effective solutions for livestock management. By prioritizing animal welfare and productivity, it supports the operational efficiency of dairy farming through scientifically developed nutritional interventions.

Recent filings

Filing Released Lang Actions
Appointment
Board/Management Information Classification · 100% confidence The document text is very short (628 characters) and contains an announcement about the appointment of Mr. Asiotsingh as Managing Director and Chief Financial Officer. It includes a brief profile and expertise, appointment date, and disclosure of relationships. There is no financial data, report, or regulatory filing mentioned. This fits the category of Board/Management Information, which covers announcements of changes in the company's board of directors or senior management.
2021-08-14 English
Updates
Board/Management Information Classification · 100% confidence The document text is very short (628 characters) and contains an announcement about the appointment of Mr. Jasiot Singh as Managing Director and Chief Financial Officer. It includes a brief profile and expertise, appointment date, and disclosure of relationships with existing directors. There is no financial data, report, or regulatory certification. This fits the category of Board/Management Information, which covers announcements of changes in the company's board of directors or senior management.
2021-08-14 English
Outcome of Board Meeting
Regulatory Filings Classification · 100% confidence The document text is extremely short (68 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report content, or any announcement text. Given the lack of any meaningful information, the document cannot be classified as a report or announcement type. It fits best as a Regulatory Filing (RNS) fallback category due to absence of specific content.
2021-08-14 English
Updates
Capital/Financing Update Classification · 95% confidence The document is a company announcement dated August 9, 2021, from Ajooni Biotech Limited addressed to the National Stock Exchange of India. It provides updates on quarterly financial results for Q1 FY22, including total income and profit after tax figures, and also announces the board's approval of a rights issue to existing shareholders. The document contains summary financial highlights and corporate actions but does not include detailed financial statements or comprehensive analysis typical of an Interim/Quarterly Report (IR). The length is 3136 characters, which is relatively short and the document reads as an announcement rather than a full report. Therefore, it fits best as a Capital/Financing Update (CAP) because it includes information about the rights issue and financial results highlights. It is not a full quarterly report, earnings release, or annual report. Hence, the classification is CAP with high confidence.
2021-08-09 English
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document contains unaudited financial results for the quarter ended June 30, 2021, including detailed financial figures such as total income, net profit/loss, earnings per share, and notes about the audit committee review and limited review by statutory auditors. It references Regulation 33 of SEBI (Listing and Other Disclosure Requirements) Regulations, 2015, which pertains to quarterly financial results filings. The document is approximately 15,000 characters long and includes substantive financial data and analysis for a quarter, not just an announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2021-08-05 English
Financial Result Updates
Regulatory Filings
2021-08-02 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.